Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MST-188 in acute lower limb ischemia with catheter-directed thrombolysis
2014-000377-40Phase 2Terminated
- Sponsor
- Mast Therapeutics, Inc.
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Acute limb ischaemia (ALI) comparing MST-188 plus catheter-directed rt-PA with Placebo plus catheter-directed rt-PA (2 arms). Primary endpoint: Change in transcutaneous oxygen pressure. Started Sep 2014; status: terminated.
02
Drugs
vepoloxamer
03
Conditions
Acute limb ischaemia (ALI)
Beyond the preview
Go deeper on 2014-000377-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000377-40.